healthcare company, focused on patients needs SANOFI AT A GLANCE

Size: px

Start display at page:

Download "healthcare company, focused on patients needs SANOFI AT A GLANCE"

Shanon York
5 years ago
Views:

1 healthcare company, focused on patients needs SANOFI AT A GLANCE

SANOFI A DIVERSIFIED GLOBAL HEALTHCARE LEADER, FOCUSED ON PATIENT NEEDS health, enhance life and respond to the potential healthcare needs of 7 billion people around the world.

2 SANOFI A DIVERSIFIED GLOBAL HEALTHCARE LEADER, FOCUSED ON PATIENT NEEDS health, enhance life and respond to the potential healthcare needs of 7 billion people around the world. We place the needs of the patient at the heart of everything we do, a philosophy that guides our R&D and the support we provide to healthcare professionals. of healthcare, our strategy driven by seven growth platforms; Emerging Markets, Diabetes, Vaccines, Consumer Healthcare, Rare Diseases, Animal Health, and Innovative Products from our internal R&D. GROUP PROFILE: One of the largest pharmaceutical groups in the world 33 billion net sales in 2013 Broad portfolio of pharmaceutical products World leader in human vaccines and animal health Present in 100 countries, including traditional and emerging markets Over 100,000 employees worldwide

SANOFI S INVESTMENT IN INNOVATION 4.8 billion invested in Global Research & Development in 2013 - representing 14.

Our overall aim is to develop medicines that target disease processes more accurately, often through the application of advanced biotechnology.

NORTH AMERICAN BOSTON Sanofi invests over 50 million in UK-based Research & Development including clinical trials EUROPEAN FRANCE GERMAN ASIAN leading

3 SANOFI S INVESTMENT IN INNOVATION 4.8 billion invested in Global Research & Development in representing 14.5% of net sales on tomorrow s therapeutic needs. Our overall aim is to develop medicines that target disease processes more accurately, often through the application of advanced biotechnology. This means medicines that are more effective and safer for patients to use. NORTH AMERICAN BOSTON Sanofi invests over 50 million in UK-based Research & Development including clinical trials EUROPEAN FRANCE GERMAN ASIAN leading academic and medical research institutions across the world, leveraging local and regional opportunities to increase access to external innovation potential filings PRIORITIES Diabetes, Fibrosis & tissue repair, Immuno diseases, Rare diseases, Oncology, Ophthalmology, Aging R&D portfolio Annual Results projects and vaccines in clinical development

4 SANOFI S SOCIAL RESPONSIBILITY Our CSR policy has four dimensions: PATIENT Access to healthcare Patient safety Innovation for patients PEOPLE Health and safety in the workplace Diversity Workforce development ETHICS Ethics in R&D Business ethics Human rights PLANET Climate change and energy Water Pharmaceuticals in the environment provide leadership and behave in an ethically responsible way. The principles by which we operate are laid down in our Corporate Social Responsibility (CSR) policy that also provide reassurance to the millions of people around the world who look to us to for help. You could say that CSR is part of our DNA. Providing access to medicines for communities across the world... The majority of the world s population has no access to appropriate healthcare, now recognised as a fundamental human right. Sanofi is dedicated to reducing this deficit by improving access to its medicines and vaccines, especially in those parts of the world where disease places a significant economic burden on communities. Since the beginning of the partnership in 2013, Sanofi employees in the UK and Ireland raised 170,000 for Teenage Cancer Trust and the Children's Medical & Research Foundation.

SANOFI GROUP IN THE UK medicines for rare diseases, consumer healthcare and animal health products. We strive to offer solutions which make a difference to people s lives whatever the need.

With four operating divisions; Diabetes, Cardiovascular, Oncology, and Commercial (focused on mature brands, generics and consumer healthcare products).

5 SANOFI GROUP IN THE UK medicines for rare diseases, consumer healthcare and animal health products. We strive to offer solutions which make a difference to people s lives whatever the need. innovations into medicines for chronic and life-threatening diseases. With four operating divisions; Diabetes, Cardiovascular, Oncology, and Commercial (focused on mature brands, generics and consumer healthcare products). third largest and fastest growing generic medicines company in Europe. Genzyme, a Sanofi company, has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. The only European company dedicated to vaccines, a joint venture between Sanofi Pasteur and MSD. The Sanofi Group has over 2,000 employees located in the UK, across the Operations, Genzyme, Merial and our A world-leading animal health company, an innovation-driven provider of products and solutions that enhance the health, well-being and performance of animals. These staff work in commercial and manufacturing and distribution. Guildford, Surrey, along with its Clinical Research Unit which runs clinical trials in the UK.

6 SANOFI GROUP LOCATIONS IN THE UK 1 FAWDON SANOFI MANUFACTURING Newcastle Upon Tyne 2 CHAPELTOWN SANOFI DISTRIBUTION South Yorkshire 3 GUILDFORD SANOFI HEAD OFFICE Surrey 4 HOLMES CHAPEL SANOFI MANUFACTURING Cheshire 5 HAVERHILL GENZYME MANUFACTURING Suffolk 1 6 OXFORD GENZYME HEAD OFFICE Oxfordshire 7 HARLOW MERIAL HEAD OFFICE Essex PIRBRIGHT MERIAL MANUFACTURING Surrey MAIDENHEAD SANOFI PASTEUR MSD HEAD OFFICE Berkshire MERIAL SANOFI GB.INF Date of Preparation: March 2014 PASTEUR GENZYME For further information please contact: Sanofi UK One Onslow Street Guildford, Surrey GU1 4YS Tel: +44 (0) Genzyme Therapeutics Ltd 4620 Kingsgate Cascade Way Oxford Business Park South Oxford OX4 2SU Tel: +44 (0) Merial Animal Health Ltd Sandringham House Harlow Essex CM19 5TG Tel: +44 (0) Sanofi Pasteur MSD Ltd Mallards Reach/Bridge Av Maidenhead SL6 1QP Tel: +44 (0)

A LEADER IN SPECIALTY CARE

A LEADER IN SPECIALTY CARE Zi Qing, Pompe Disease, Taiwan SCIENCE-DRIVEN, PATIENT-FOCUSED Patients and science are at the center of everything we do, defining and uniting our efforts across rare diseases,